Literature DB >> 25129206

Post-mortem 7.0-tesla magnetic resonance study of cortical microinfarcts in neurodegenerative diseases and vascular dementia with neuropathological correlates.

J De Reuck1, V Deramecourt2, F Auger3, N Durieux3, C Cordonnier4, D Devos5, L Defebvre6, C Moreau6, D Caparros-Lefebvre7, R Bordet8, C A Maurage9, F Pasquier10, D Leys4.   

Abstract

BACKGROUND: Until recently cortical microinfarcts (CMIs) were considered as the invisible lesions in clinical-radiological correlation studies that rely on conventional structural magnetic resonance imaging. The present study investigates the presence of CMIs on 7.0-T magnetic resonance imaging (MRI) in post-mortem brains with different neurodegenerative and cerebrovascular diseases.
MATERIALS AND METHODS: One hundred-seventy five post-mortem brains, composed of 37 with pure Alzheimer's disease (AD), 12 with AD associated to cerebral amyloid angiopathy (AD-CAA), 38 with frontotemporal lobar degeneration, 12 with amyotrophic lateral sclerosis, 16 with Lewy body disease (LBD), 21 with progressive supranuclear palsy, 18 with vascular dementia (VaD) and 21 controls were examined. According to their size several types of CMIs were detected on 3 coronal sections of a cerebral hemisphere with 7.0-T MRI and compared to the mean CMI load observed on histological examination of one standard separate coronal section of a cerebral hemisphere at the level of the mamillary body.
RESULTS: Overall CMIs were significantly prevalent in those brains with neurodegenerative and cerebrovascular diseases associated to CAA compared to those without CAA. VaD, AD-CAA and LBD brains had significantly more CMIs compared to the controls. While all types of CMIs were increased in VaD and AD-CAA brains, a predominance of the smallest ones was observed in the LBD brains.
CONCLUSIONS: The present study shows that 7.0-T MRI allows the detection of several types of MICs and their contribution to the cognitive decline in different neurodegenerative and cerebrovascular diseases.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  7.0-T magnetic resonance imaging; Alzheimer's disease; Cerebral amyloid angiopathy; Lewy body disease; Post-mortem cortical microinfarcts; Vascular dementia

Mesh:

Year:  2014        PMID: 25129206     DOI: 10.1016/j.jns.2014.07.061

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  20 in total

Review 1.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  MRI detection of cerebral microbleeds: size matters.

Authors:  Sven Haller; Max Scheffler; Rares Salomir; François R Herrmann; Gabriel Gold; Marie-Louise Montandon; Enikö Kövari
Journal:  Neuroradiology       Date:  2019-08-08       Impact factor: 2.804

Review 3.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

4.  A within-coil optical prospective motion-correction system for brain imaging at 7T.

Authors:  Phillip DiGiacomo; Julian Maclaren; Murat Aksoy; Elizabeth Tong; Mackenzie Carlson; Bryan Lanzman; Syed Hashmi; Ronald Watkins; Jarrett Rosenberg; Brian Burns; Timothy W Skloss; Dan Rettmann; Brian Rutt; Roland Bammer; Michael Zeineh
Journal:  Magn Reson Med       Date:  2020-02-20       Impact factor: 4.668

Review 5.  Neuropathology of Vascular Brain Health: Insights From Ex Vivo Magnetic Resonance Imaging-Histopathology Studies in Cerebral Small Vessel Disease.

Authors:  Susanne J van Veluw; Konstantinos Arfanakis; Julie A Schneider
Journal:  Stroke       Date:  2022-01-10       Impact factor: 7.914

6.  Topographic distribution of white matter changes and lacunar infarcts in neurodegenerative and vascular dementia syndromes: A post-mortem 7.0-tesla magnetic resonance imaging study.

Authors:  Jacques De Reuck; Florent Auger; Nicolas Durieux; Charlotte Cordonnier; Vincent Deramecourt; Florence Pasquier; Claude-Alain Maurage; Didier Leys; Regis Bordet
Journal:  Eur Stroke J       Date:  2016-05-18

Review 7.  Detection, risk factors, and functional consequences of cerebral microinfarcts.

Authors:  Susanne J van Veluw; Andy Y Shih; Eric E Smith; Christopher Chen; Julie A Schneider; Joanna M Wardlaw; Steven M Greenberg; Geert Jan Biessels
Journal:  Lancet Neurol       Date:  2017-07-14       Impact factor: 44.182

8.  Comparison of Routine Brain Imaging at 3 T and 7 T.

Authors:  Elisabeth Springer; Barbara Dymerska; Pedro Lima Cardoso; Simon Daniel Robinson; Christian Weisstanner; Roland Wiest; Benjamin Schmitt; Siegfried Trattnig
Journal:  Invest Radiol       Date:  2016-08       Impact factor: 6.016

Review 9.  Post-mortem assessment in vascular dementia: advances and aspirations.

Authors:  Kirsty E McAleese; Irina Alafuzoff; Andreas Charidimou; Jacques De Reuck; Lea T Grinberg; Atticus H Hainsworth; Tibor Hortobagyi; Paul Ince; Kurt Jellinger; Jing Gao; Raj N Kalaria; Gabor G Kovacs; Enikö Kövari; Seth Love; Mara Popovic; Olivia Skrobot; Ricardo Taipa; Dietmar R Thal; David Werring; Stephen B Wharton; Johannes Attems
Journal:  BMC Med       Date:  2016-08-26       Impact factor: 8.775

10.  Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies.

Authors:  Daniel Ferreira; Zuzana Nedelska; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Christopher G Schwarz; Hugo Botha; Matthew L Senjem; Julie A Fields; David S Knopman; Rodolfo Savica; Tanis J Ferman; Neill R Graff-Radford; Val J Lowe; Clifford R Jack; Ronald C Petersen; Afina W Lemstra; Marleen van de Beek; Frederik Barkhof; Frederic Blanc; Paulo Loureiro de Sousa; Nathalie Philippi; Benjamin Cretin; Catherine Demuynck; Jakub Hort; Ketil Oppedal; Bradley F Boeve; Dag Aarsland; Eric Westman; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2021-05-14       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.